Journal Article
. 2020 Jun; 11:806.
doi: 10.3389/fimmu.2020.00806.

Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis

Yiding Li 1 Zhiming Wang 1 Huayu Lin 1 Lisha Wang 1 Xiangyu Chen 1 Qiao Liu 1 Qianfei Zuo 1 Jianjun Hu 2 Haoqiang Wang 3 Junyi Guo 4 Luoyingzi Xie 1 Jianfang Tang 1 Zhirong Li 1 Li Hu 1 Litian Xu 5 Xinyuan Zhou 1 Lilin Ye 1 Qizhao Huang 6 Lifan Xu 1 
Affiliations
  • PMID: 32477338
  •     58 References
  •     5 citations

Abstract

During tumorigenesis, tumor infiltrating regulatory T (Treg) cells restrict the function of effector T cells in tumor microenvironment and thereby promoting tumor growth. The anti-tumor activity of effector T cells can be therapeutically unleashed, and is now being exploited for the treatment of various types of human cancers. However, the immune suppressive function of Treg cells remains a major hurdle to broader effectiveness of tumor immunotherapy. In this article, we reported that the deletion of Bcl6 specifically in Treg cells led to stunted tumor growth, which was caused by impaired Treg cell responses. Notably, Bcl6 is essential in maintaining the lineage stability of Treg cells in tumor microenvironment. Meanwhile, we found that the absence of follicular regulatory T (Tfr) cells, which is a result of Bcl6 deletion in Foxp3+ cells, was dispensable for tumor control. Importantly, the increased Bcl6 expression in Treg cells is associated with poor prognosis of human colorectal cancer and lymph node metastasis of skin melanoma. Furthermore, Bcl6 deletion in Treg cells exhibits synergistic effects with immune checkpoint blockade therapy. Collectively, these results indicate that Bcl6 actively participates in regulating Treg cell immune responses during tumorigenesis and can be exploited as a therapeutic target of anti-tumor immunity.

Keywords: Bcl6; Treg; anti-tumor immunity; checkpoint blockade therapy; tumorigenesis.

Regulatory T cells in cancer immunotherapy.
Atsushi Tanaka, Shimon Sakaguchi.
Cell Res, 2016 Dec 21; 27(1). PMID: 27995907    Free PMC article.
Highly Cited. Review.
Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation.
Yosuke Togashi, Hiroyoshi Nishikawa.
Curr Top Microbiol Immunol, 2017 Sep 08; 410. PMID: 28879523
Review.
Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6.
Patrycja Czerwinska, Marcin Rucinski, +6 authors, Andrzej Mackiewicz.
Oncoimmunology, 2020 Feb 01; 9(1). PMID: 32002306    Free PMC article.
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.
Daisuke Sugiyama, Hiroyoshi Nishikawa, +10 authors, Shimon Sakaguchi.
Proc Natl Acad Sci U S A, 2013 Oct 16; 110(44). PMID: 24127572    Free PMC article.
Highly Cited.
T cell immune response within B-cell follicles.
Qizhao Huang, Lifan Xu, Lilin Ye.
Adv Immunol, 2019 Nov 09; 144. PMID: 31699216
Review.
Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response.
Thorsten R Mempel, Francesco Marangoni.
Immunol Rev, 2019 Apr 13; 289(1). PMID: 30977195    Free PMC article.
Review.
The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.
Lifan Xu, Yi Cao, +13 authors, Yuzhang Wu.
Nat Immunol, 2015 Jul 28; 16(9). PMID: 26214740
Highly Cited.
Control of regulatory T cell development by the transcription factor Foxp3.
Shohei Hori, Takashi Nomura, Shimon Sakaguchi.
Science, 2003 Jan 11; 299(5609). PMID: 12522256
Highly Cited.
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
Ye Zheng, Ashutosh Chaudhry, +7 authors, Alexander Y Rudensky.
Nature, 2009 Feb 03; 458(7236). PMID: 19182775    Free PMC article.
Highly Cited.
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.
Laura M McLane, Mohamed S Abdel-Hakeem, E John Wherry.
Annu Rev Immunol, 2019 Jan 25; 37. PMID: 30676822
Highly Cited. Review.
Treg cell-based therapies: challenges and perspectives.
Caroline Raffin, Linda T Vo, Jeffrey A Bluestone.
Nat Rev Immunol, 2019 Dec 08; 20(3). PMID: 31811270    Free PMC article.
Review.
Affinity for self antigen selects Treg cells with distinct functional properties.
Lena Wyss, Brian D Stadinski, +9 authors, Ed Palmer.
Nat Immunol, 2016 Aug 02; 17(9). PMID: 27478940    Free PMC article.
CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets.
Kate S Smigiel, Elizabeth Richards, +4 authors, Daniel J Campbell.
J Exp Med, 2014 Jan 01; 211(1). PMID: 24378538    Free PMC article.
Highly Cited.
Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, +26 authors, Walter J Urba.
N Engl J Med, 2010 Jun 08; 363(8). PMID: 20525992    Free PMC article.
Highly Cited.
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.
Mark J Selby, John J Engelhardt, +4 authors, Alan J Korman.
Cancer Immunol Res, 2014 Apr 30; 1(1). PMID: 24777248
Highly Cited.
Bcl6 mediates the development of T follicular helper cells.
Roza I Nurieva, Yeonseok Chung, +5 authors, Chen Dong.
Science, 2009 Jul 25; 325(5943). PMID: 19628815    Free PMC article.
Highly Cited.
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
Ashutosh Chaudhry, Dipayan Rudra, +4 authors, Alexander Y Rudensky.
Science, 2009 Oct 03; 326(5955). PMID: 19797626    Free PMC article.
Highly Cited.
Using immunotherapy to boost the abscopal effect.
Wilfred Ngwa, Omoruyi Credit Irabor, +3 authors, Silvia C Formenti.
Nat Rev Cancer, 2018 Feb 17; 18(5). PMID: 29449659    Free PMC article.
Highly Cited. Review.
IL-35-mediated induction of a potent regulatory T cell population.
Lauren W Collison, Vandana Chaturvedi, +13 authors, Dario A A Vignali.
Nat Immunol, 2010 Oct 19; 11(12). PMID: 20953201    Free PMC article.
Highly Cited.
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions.
Yeonseok Chung, Shinya Tanaka, +11 authors, Chen Dong.
Nat Med, 2011 Jul 26; 17(8). PMID: 21785430    Free PMC article.
Highly Cited.
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Frederick Arce Vargas, Andrew J S Furness, +32 authors, Sergio A Quezada.
Cancer Cell, 2018 Mar 27; 33(4). PMID: 29576375    Free PMC article.
Highly Cited.
Regulatory T cells: how do they suppress immune responses?
Shimon Sakaguchi, Kajsa Wing, +2 authors, Tomoyuki Yamaguchi.
Int Immunol, 2009 Sep 10; 21(10). PMID: 19737784
Highly Cited. Review.
Follicular Helper T Cells.
Carola G Vinuesa, Michelle A Linterman, Di Yu, Ian C M MacLennan.
Annu Rev Immunol, 2016 Feb 26; 34. PMID: 26907215
Highly Cited. Review.
Understanding Subset Diversity in T Cell Memory.
Stephen C Jameson, David Masopust.
Immunity, 2018 Feb 22; 48(2). PMID: 29466754    Free PMC article.
Highly Cited. Review.
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.
Yannick Bulliard, Rose Jolicoeur, +6 authors, Jennifer L Brogdon.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982    Free PMC article.
Highly Cited.
A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1.
Shin Foong Ngiow, Arabella Young, +4 authors, Mark J Smyth.
Cancer Res, 2015 Jul 26; 75(18). PMID: 26208901
Highly Cited.
The transcriptional repressor Bcl6 controls the stability of regulatory T cells by intrinsic and extrinsic pathways.
Deepali V Sawant, Hao Wu, +3 authors, Alexander L Dent.
Immunology, 2014 Sep 30; 145(1). PMID: 25262912    Free PMC article.
Once a Treg, always a Treg?
Deepali V Sawant, Dario A A Vignali.
Immunol Rev, 2014 Apr 10; 259(1). PMID: 24712466    Free PMC article.
Highly Cited. Review.
Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation.
Robert J Johnston, Amanda C Poholek, +6 authors, Shane Crotty.
Science, 2009 Jul 18; 325(5943). PMID: 19608860    Free PMC article.
Highly Cited.
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.
George Plitas, Catherine Konopacki, +5 authors, Alexander Y Rudensky.
Immunity, 2016 Nov 17; 45(5). PMID: 27851913    Free PMC article.
Highly Cited.
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients.
Koji Kurose, Yoshihiro Ohue, +13 authors, Eiichi Nakayama.
Clin Cancer Res, 2015 Oct 03; 21(19). PMID: 26429981
Highly Cited.
CTLA-4 control over Foxp3+ regulatory T cell function.
Kajsa Wing, Yasushi Onishi, +5 authors, Shimon Sakaguchi.
Science, 2008 Oct 11; 322(5899). PMID: 18845758
Highly Cited.
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
Tyler J Curiel, George Coukos, +18 authors, Weiping Zou.
Nat Med, 2004 Aug 24; 10(9). PMID: 15322536
Highly Cited.
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells.
Marco De Simone, Alberto Arrigoni, +28 authors, Massimiliano Pagani.
Immunity, 2016 Nov 17; 45(5). PMID: 27851914    Free PMC article.
Highly Cited.
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
Meghan A Koch, Glady's Tucker-Heard, +3 authors, Daniel J Campbell.
Nat Immunol, 2009 May 05; 10(6). PMID: 19412181    Free PMC article.
Highly Cited.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, +21 authors, Luis Paz-Ares.
N Engl J Med, 2018 Apr 17; 378(22). PMID: 29658845    Free PMC article.
Highly Cited.
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.
Yosuke Togashi, Kohei Shitara, Hiroyoshi Nishikawa.
Nat Rev Clin Oncol, 2019 Feb 02; 16(6). PMID: 30705439
Highly Cited. Review.
Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.
Deepali V Sawant, Sarita Sehra, +9 authors, Alexander L Dent.
J Immunol, 2012 Oct 12; 189(10). PMID: 23053511    Free PMC article.
Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.
Ran He, Shiyue Hou, +24 authors, Lilin Ye.
Nature, 2016 Aug 09; 537(7620). PMID: 27501245
Highly Cited.
Mechanisms of foxp3+ T regulatory cell-mediated suppression.
Ethan M Shevach.
Immunity, 2009 May 26; 30(5). PMID: 19464986
Highly Cited. Review.
T follicular regulatory cells.
Peter T Sage, Arlene H Sharpe.
Immunol Rev, 2016 Apr 19; 271(1). PMID: 27088919
Highly Cited. Review.
The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment.
Di Yu, Sudha Rao, +14 authors, Carola G Vinuesa.
Immunity, 2009 Jul 28; 31(3). PMID: 19631565
Highly Cited.
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
B Salomon, D J Lenschow, +4 authors, J A Bluestone.
Immunity, 2000 May 05; 12(4). PMID: 10795741
Highly Cited.
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
James Larkin, Vanna Chiarion-Sileni, +28 authors, Jedd D Wolchok.
N Engl J Med, 2015 Jun 02; 373(1). PMID: 26027431    Free PMC article.
Highly Cited.
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
Yisong Y Wan, Richard A Flavell.
Nature, 2007 Jan 16; 445(7129). PMID: 17220876
Highly Cited.
Dynamic regulation of T follicular regulatory cell responses by interleukin 2 during influenza infection.
Davide Botta, Michael J Fuller, +8 authors, André Ballesteros-Tato.
Nat Immunol, 2017 Sep 12; 18(11). PMID: 28892471    Free PMC article.
Highly Cited.
Bcl6 expression specifies the T follicular helper cell program in vivo.
Xindong Liu, Xiaowei Yan, +10 authors, Chen Dong.
J Exp Med, 2012 Sep 19; 209(10). PMID: 22987803    Free PMC article.
Highly Cited.
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Takuro Saito, Hiroyoshi Nishikawa, +19 authors, Shimon Sakaguchi.
Nat Med, 2016 Apr 26; 22(6). PMID: 27111280
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Regulatory T cells, tumour immunity and immunotherapy.
Weiping Zou.
Nat Rev Immunol, 2006 Mar 25; 6(4). PMID: 16557261
Highly Cited. Review.
TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.
Bi-Huei Yang, Ke Wang, +10 authors, Wenxian Fu.
Cell Rep, 2019 Jun 20; 27(12). PMID: 31216480    Free PMC article.
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.
François Ghiringhelli, Cedric Menard, +7 authors, Bruno Chauffert.
Cancer Immunol Immunother, 2006 Sep 09; 56(5). PMID: 16960692
Highly Cited.
Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
Jason D Fontenot, Jeffrey P Rasmussen, +3 authors, Alexander Y Rudensky.
Immunity, 2005 Mar 23; 22(3). PMID: 15780990
Highly Cited.
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment.
Yasuko Tada, Yosuke Togashi, +7 authors, Kohei Shitara.
J Immunother Cancer, 2018 Oct 14; 6(1). PMID: 30314524    Free PMC article.
Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages.
Arpita Mondal, Deepali Sawant, Alexander L Dent.
J Immunol, 2010 Mar 10; 184(8). PMID: 20212093
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.
Shetal A Patel, Andy J Minn.
Immunity, 2018 Mar 22; 48(3). PMID: 29562193    Free PMC article.
Highly Cited. Review.
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome.
Yingzi Ge, Christoph Domschke, +9 authors, Florian Schuetz.
Cancer Immunol Immunother, 2011 Sep 15; 61(3). PMID: 21915801
The Kinase mTORC1 Promotes the Generation and Suppressive Function of Follicular Regulatory T Cells.
Lifan Xu, Qizhao Huang, +17 authors, Lilin Ye.
Immunity, 2017 Sep 21; 47(3). PMID: 28930662
Highly Cited.
The multifaceted functions of follicular regulatory T cells.
Peter T Sage, Arlene H Sharpe.
Curr Opin Immunol, 2020 Nov 12; 67. PMID: 33176227    Free PMC article.
Review.
Critical Roles of Balanced T Helper 9 Cells and Regulatory T Cells in Allergic Airway Inflammation and Tumor Immunity.
Muhua Huang, Jingcheng Dong.
J Immunol Res, 2021 Mar 23; 2021. PMID: 33748292    Free PMC article.
Review.
ZBTB Transcription Factors: Key Regulators of the Development, Differentiation and Effector Function of T Cells.
Zhong-Yan Cheng, Ting-Ting He, +2 authors, Jun Wang.
Front Immunol, 2021 Aug 06; 12. PMID: 34349770    Free PMC article.
Review.
Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis.
Tingwei Liu, Jiacheng Shen, Qizhi He, Shaohua Xu.
Front Genet, 2022 Mar 04; 13. PMID: 35237300    Free PMC article.
Transcriptional inhibition of miR-486-3p by BCL6 upregulates Snail and induces epithelial-mesenchymal transition during radiation-induced pulmonary fibrosis.
Ziyan Yan, Xingkun Ao, +10 authors, Yongqing Gu.
Respir Res, 2022 Apr 29; 23(1). PMID: 35484551    Free PMC article.